here it shows image which will print

Professor Klaus Müller (F. Hoffmann-La Roche AG) has been designated by an International Selection Committee as the winner of the Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery. Dr. Müller is recognized for his leadership in the development of a broad range of new technologies for improving drug discovery research, with a special focus on computational chemistry, bioinformatics, structure-property analytics and correlation methodologies. At Roche, Dr. Müller set up new corporate information management systems for combined chemical and biological data mining, implementing combinatorial chemistry, developing the "Smart Roche Compound Repository" and (ultra)-high-throughput screening technologies. Over his entire career, he has fostered the development of new key technologies in pharmaceutical research, setting up close and continuous collaborations between technology and therapeutic areas.

This prestigious EFMC Award is conferred every two years to encourage innovation and investigation in technological developments related to drug discovery and it is given for the discovery, evaluation and use of new technologies (see http://www.efmc.info).

The Prous Institute - Overton and Meyer Award will be presented on Sunday, September 5, 2010 during the opening ceremony of the XXIst International Symposium on Medicinal Chemistry (EFMC-ISMC), which will be held in Brussels on September 5-9, 2010. The Award plenary Lecture is scheduled for September 8 from 9:45 until 10:30 (including the introduction).  More information on EFMC-ISMC is also available on the website www.ismc2010.org.